Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» intepirdine
intepirdine
Axovant axes neuroscience drug, focuses on gene therapies
Pharmaforum
Wed, 12/12/18 - 10:02 am
Axovant
intepirdine
nelotanserin
gene therapy
A new Alzheimer’s drug, once worth billions, is headed for the trash
Stat
Mon, 01/8/18 - 11:45 am
Alzheimer's disease
Axovant Sciences
intepirdine
dementia with Lewy bodies
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
After Intepirdine Flunked in Alzheimer’s Disease, Is Axovant Sciences a Buy?
Motley Fool
Tue, 10/3/17 - 11:37 am
Axovant Sciences
Alzheimer's disease
intepirdine
Axovant's closely watched Alzheimer's drug fails late-stage trial
BioPharma Dive
Tue, 09/26/17 - 11:36 am
Axovant Sciences
Alzheimer's disease
clinical trials
intepirdine
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
Stat
Thu, 09/7/17 - 09:35 am
Alzheimer's disease
Axovant
David Hung
dimebon
Medivation
intepirdine
Upcoming events – GSK’s shingles panel and Axovant takes on Alzheimer’s
EP Vantage
Sat, 08/26/17 - 07:46 pm
GSK
shingles
vaccines
Shingrix
Axovant
Alzheimer's disease
intepirdine
Is This the Next Home-Run Biotech Stock?
Motley Fool
Wed, 06/28/17 - 10:42 pm
biotech
Axovant Sciences
intepirdine
RVT-101